Makes a lot of sense, Moon, and could have very well unfolded that way. The fact of the matter, though, is that the conservative CEO has the company in a "lose and the company may not survive scenario", with the stock price in shambles.
Due to the lack of transparency, until the company is actually sold, what JT and the leadership have planned is an open question. And as I have laid out in previous postings, the company can be sold at a good, reasonable price even with the litigation overhang, because in the hands of BP with the resources and right strategic planning, Vascepa will generate profits many billions of dollars over the purchase price.
News 
Market Data 
Discover 
AI
